Liu X, Ma J, Qiu X, Hong D, et al. Dupilumab, an emerging therapeutic choice for recalcitrant subepidermal autoimmune bullous diseases: a case series of three patients. Eur J Dermatol 2021;31:846-847.
PMID: 35107075